Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

“Arcturus is actively engaged with the U.S. government to prepare for the next pandemic, and clearance to proceed into the clinic with our STARR self-amplifying mRNA ... potential vaccine to protect ...

Hawaii is the only US state that hasn't reported H5N1 avian flu in birds or animals. The state hasn't reported any recent ...

In 2023, Moderna started a phase 1/2 study of an experimental pandemic influenza vaccines collectively known as mRNA-1018, which are designed to provide protection against H5 and H7 avian ...

Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ETCompany ParticipantsEdward Berg - Senior Vice President and ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory ... along with a seasonal influenza candidate also in phase 2 and one for avian influenza in phase ...

H5N1 Virus Isolated from Infected Dairy Worker Is 100% Lethal in Ferrets, but Does Not Appear to Be Circulating in Nature Anymore Oct. 28, 2024 — A strain of H5N1 avian influenza virus found in ...

In light of the bird flu outbreak, we've intensified business development ... There are other products like DNASE-1 used in vaccine production of mRNA vaccines that aren't necessarily needed in the ...